Hear from our scientists about the latest funnel web spider research

Results suggest this spider venom could transform heart transplant and heart attack treatment

We’ve been taught to fear it all our lives, but incredibly the funnel web spider could hold the key to the world’s first cardiac protective drug to be administered after a heart attack.

Amazingly, the possibilities don't stop there. It could also boost heart transplantation rates, and help treat victims of stroke and cardiac arrest.

Watch this video from Professors Peter Macdonald and Bob Graham who explain how this research could help fight heart disease all over the world.


A generous gift from you today can help progress this vital research to clinical trials. It’s thought this could be achieved as early as 2023.

Donate today to help our scientists unlock the life-saving potential of funnel web spider venom.

Donations $2 and over are tax deductible. The Victor Chang Cardiac Research Institute has an interest in the trust company which holds the licence to develop the patents in relation to the discovery, having worked in collaboration with scientists at the Institute for Molecular Bioscience, University of Queensland.

Acknowledgement of Country

The Victor Chang Cardiac Research Institute acknowledges the traditional custodians of the land, the Gadigal of the Eora nation, on which we meet, work, and discover.
Our Western Australian laboratories pay their respect to the Whadjuk Noongar who remain as the spiritual and cultural custodians of their land.

Close